Weijian Guo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer (NCT05447715) | Weijian Guo | 2022-08-31 |
Track Weijian Guo automatically
Every clearance here is in the API, with alerts when new ones post.